Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy (Q40434688)

20 September 2017

1 reference

title

Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy (English)

1 reference

20 September 2017

Oosterwijk C

1

1 reference

20 September 2017

Höppener JW

series ordinal

2

1 reference

20 September 2017

van Hulst KL

series ordinal

3

1 reference

20 September 2017

Lips CJ

series ordinal

4

1 reference

20 September 2017

1 August 1995

1 reference

International Journal of Pancreatology

20 September 2017

1 reference

20 September 2017

18

1 reference

20 September 2017

1

1 reference

20 September 2017

7-14

1 reference

Relationship between islet amyloid polypeptide (IAPP) deposition and insulin response and beta-cell volume in diabetes mellitus

20 September 2017

1 reference

12 December 2020

Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling

1 reference

12 December 2020

Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes

1 reference

12 December 2020

Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging

1 reference

12 December 2020

1 reference

12 December 2020

Islet amyloid: an enigma of type 2 diabetes

1 reference

12 December 2020

Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans

1 reference

12 December 2020

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

12 December 2020

Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas

1 reference

12 December 2020

Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells

1 reference

12 December 2020

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation

1 reference

12 December 2020

[Amyloid of islets of Langerhans and its relation to diabetes mellitus (author's transl)]

1 reference

12 December 2020

Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia.

1 reference

12 December 2020

Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis.

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor

1 reference

12 December 2020

Type II diabetes: search for primary defects

1 reference

12 December 2020

Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide

1 reference

12 December 2020

Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients

1 reference

12 December 2020

Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide

1 reference

12 December 2020

Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus

1 reference

12 December 2020

Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice

1 reference

12 December 2020

Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients

1 reference

12 December 2020

Islet amyloid polypeptide-derived amyloid deposition increases along with the duration of type 2 diabetes mellitus

1 reference

12 December 2020

Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs.

1 reference

12 December 2020

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

1 reference

12 December 2020

Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets

1 reference

12 December 2020

Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus

1 reference

12 December 2020

Induction of acute hyperglycemia, hyperlactemia and hypocalcemia in fed and fasted BALB/c mice by intravenous amylin injection

1 reference

12 December 2020

Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia

1 reference

12 December 2020

Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats

1 reference

12 December 2020

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1 reference

12 December 2020

Strong promoter activity of human and rat islet amyloid polypeptide/amylin gene constructs in mouse beta cells (beta TC 3)

1 reference

12 December 2020

Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

12 December 2020

Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans

1 reference

12 December 2020

Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice

1 reference

12 December 2020

Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway

1 reference

12 December 2020

Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.

1 reference

12 December 2020

Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Insulin resistance caused by amylin in conscious rats is independent of induced hypocalcemia and fades during long-term exposure

1 reference

12 December 2020

Effects of islet amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver

1 reference

12 December 2020

Beta-cell tropin- and glucose-induced hypersecretion of insulin and amylin from perfused fatty rat pancreas

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Genetic and environmental determinants of non‐insulin‐dependent diabetes mellitus (NIDDM)

1 reference

12 December 2020

Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians

1 reference

12 December 2020

Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series

1 reference

12 December 2020

Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues

1 reference

12 December 2020

Regulation of islet amyloid polypeptide in human pancreatic islets

1 reference

12 December 2020

The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes

1 reference

12 December 2020

Islet amyloid polypeptide (IAPP/amylin) causes insulin resistance in perfused rat hindlimb muscle

1 reference

12 December 2020

Islet Amyloid Polypeptide and Insulin Expression Are Controlled Differently in Primary and Transformed Islet Cells

1 reference

12 December 2020

Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell

1 reference

12 December 2020

Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes.

1 reference

12 December 2020

Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).

1 reference

12 December 2020

Pathogenesis of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Hypersecretion of IAPP from the islets of VMH-lesioned rats and obese Zucker rats

1 reference

12 December 2020

Multiple cis-acting domains mediate basal and adenosine 3',5'-monophosphate-dependent glucagon gene transcription in a mouse neuroendocrine cell line

1 reference

12 December 2020

Amylin concentrations and glucose control

1 reference

12 December 2020

Non-linkage of the islet amyloid polypeptide gene with Type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

12 December 2020

Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population.

1 reference

12 December 2020

Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.

1 reference

12 December 2020

No constant relationship between islet amyloid polypeptide (IAPP) and insulin expression in insulinomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02825416

1 reference

20 September 2017

1 reference